Vision Augmentation Technology LLC vs. SICK AG: 3D Vision Sensor Patent Dispute Resolved in 66 Days
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Vision Augmentation Technology LLC v. SICK AG |
| Case Number | 4:25-cv-05231 (S.D. Tex.) |
| Court | Texas Southern District Court |
| Duration | Nov 2, 2025 – Jan 7, 2026 66 Days |
| Outcome | Dismissal Without Prejudice |
| Patents at Issue | |
| Accused Products | SICK AG Visionary-S 3D Vision Sensors |
Introduction
In a patent infringement dispute that concluded in just 66 days, Vision Augmentation Technology LLC filed suit against industrial sensor manufacturer SICK AG in the Texas Southern District Court, alleging infringement of U.S. Patent No. 7,433,021B2 — a patent covering stereoscopic and 3D vision technology. The case, filed November 2, 2025, and closed January 7, 2026, ended with a dismissal without prejudice following notice of resolution between the parties — signaling a likely settlement before the matter could advance to substantive litigation.
The rapid closure of this 3D vision sensor patent infringement case offers meaningful signals for patent practitioners, in-house IP counsel, and technology companies operating in the machine vision and industrial sensing space. With SICK AG’s Visionary-S product line at the center of the dispute, and prominent IP litigation firm Fish & Richardson LLP defending, the case reflects broader trends in how non-practicing entities pursue and resolve patent assertions against established industrial technology companies.
Case Overview
The Parties
⚖️ Plaintiff
Patent-holding entity asserting rights in stereoscopic camera and 3D vision sensing technology, leveraging U.S. Patent No. 7,433,021B2.
🛡️ Defendant
Globally recognized German manufacturer of industrial sensors, machine vision systems, and automation technology, targeted for its Visionary-S product line.
The Patent at Issue
This case involved U.S. Patent No. 7,433,021B2 (Application No. US11/161,044), covering stereoscopic camera systems and 3D vision sensing technology. The patent protects technology foundational to depth-sensing and spatial imaging — core functionalities embedded in modern machine vision platforms.
- • US7433021B2 — Stereoscopic camera systems and 3D vision sensing
The Accused Products
The complaint targeted SICK AG’s **Stereoscopic Camera Systems**, **Visionary-S 3D Vision Sensors**, and the broader **Visionary-S product family** — commercially active products in industrial automation markets, adding commercial weight to the infringement allegations.
Legal Representation
The plaintiff was represented by Bradford J. Black of Bradford Black PC. The defendant, SICK AG, was defended by Matthew Alan Colvin of Fish & Richardson LLP, one of the most recognized intellectual property litigation firms in the United States.
Developing 3D vision technology?
Check if your product design might infringe this or related patents before launch.
The Verdict & Legal Analysis
Litigation Timeline & Procedural History
The case was filed in the **Texas Southern District Court**, presided over by Chief Judge Alfred H. Bennett. The litigation did not advance beyond its preliminary stage. The 66-day duration from filing to closure is notably brief — far shorter than the average patent infringement case, which typically spans 18 to 36 months through trial. This timeline is consistent with pre-litigation settlement negotiations or rapid licensing resolution upon engagement of defense counsel.
| Complaint Filed | November 2, 2025 |
| Case Closed | January 7, 2026 |
| Total Duration | 66 Days |
| Scheduled ICMC | January 14, 2026 (vacated) |
Outcome
On the parties’ joint **Notice of Resolution**, Chief Judge Alfred H. Bennett entered an order **dismissing the action without prejudice**, preserving each party’s right to move for reinstatement within **60 days** if the resolution was not ultimately consummated. All pending deadlines — including the January 14, 2026 Initial Case Management Conference — were vacated, and the clerk was directed to close the case for administrative purposes.
No damages amount was publicly disclosed. No injunctive relief was granted or denied on the merits. The dismissal without prejudice structure is procedurally significant: it provides a built-in mechanism to reopen the case should any settlement agreement fail to close, functioning as a litigation backstop for both parties.
Verdict Cause Analysis
The case was brought as a straightforward **infringement action** under the patent statutes. Because the matter resolved prior to any substantive judicial rulings, there is no published claim construction order, validity analysis, or infringement finding to analyze. However, the near-immediate resolution suggests either pre-filing settlement discussions were already underway, or engagement of specialized counsel by SICK AG prompted a rapid licensing negotiation that foreclosed the need for extended litigation.
The choice of dismissal *without prejudice* (rather than with prejudice or pursuant to a stipulated dismissal with prejudice) preserves Vision Augmentation Technology LLC’s ability to refile. This form of dismissal is commonly used when parties reach an agreement in principle but require additional time to finalize and execute definitive settlement documentation.
Legal Significance
While this case produced no precedential rulings, its rapid resolution underscores the **settlement-dominant trajectory** of patent infringement actions involving well-resourced defendants represented by specialized IP litigation counsel. The involvement of Fish & Richardson LLP often signals an aggressive, early-stage defense posture that can accelerate licensing discussions.
US7433021B2 remains a live patent asset. Patent practitioners should note that a dismissal without prejudice does not extinguish the patent’s assertion potential against other defendants or in future proceedings.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in 3D vision sensor design. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View the patent and its related prior art
- See which companies are most active in 3D vision patents
- Understand assertion trends in machine vision
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Stereoscopic and 3D vision sensing
US7433021B2
Actively asserted patent
Strategy Options
Licensing or design-around possible
✅ Key Takeaways
Dismissal without prejudice with a 60-day reinstatement window signals an in-progress settlement, not a substantive ruling.
Search related case law →The involvement of specialized defense counsel can significantly compress litigation timelines and drive faster resolution.
Explore counsel trends →US7433021B2 remains an assertable patent; monitor for future actions against other defendants in the 3D vision sensor space.
Monitor this patent →3D vision and stereoscopic sensor technology carries meaningful patent assertion risk; FTO reviews are advisable before market entry.
Start FTO analysis for my product →Short-duration cases like this one rarely generate claim construction guidance, leaving underlying patent scope unresolved and potentially applicable to competing products.
Analyze patent scope →Frequently Asked Questions
The case involved U.S. Patent No. 7,433,021B2 (Application No. US11/161,044), covering stereoscopic camera and 3D vision sensing technology.
The parties filed a Notice of Resolution, prompting Chief Judge Alfred H. Bennett to dismiss the action without prejudice, with a 60-day window to reinstate if the resolution was not finalized.
While no precedential ruling was issued, the case confirms that US7433021B2 is being actively asserted and that machine vision product developers should conduct FTO analysis for stereoscopic and depth-sensing technologies.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
PatSnap IP Intelligence Team
Patent Research & Competitive Intelligence · PatSnap
This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.
The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.
References
- United States District Court, Southern District of Texas — Case 4:25-cv-05231
- U.S. Patent and Trademark Office — Patent US7433021B2
- Texas Southern District Court — Official Website
- Fish & Richardson LLP — Official Website
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.
📑 Table of Contents
🚀 PatSnap Eureka IP Tools
🔍Novelty Search
Find prior art instantly
Patent Drafting
AI-assisted claim writing
FTO Analysis
Assess infringement risk
Concerned About Your Product?
Don’t wait for litigation. Check your product’s freedom to operate now with AI-powered analysis.
Run FTO for My Product